Market Research Logo

TearLab Corp (TEAR) - Financial and Strategic SWOT Analysis Review

TearLab Corp (TEAR) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

TearLab Corp (TearLab) is an ophthalmic device company. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. The company conducts it research and development activities through its wholly-owned subsidiary, TearLab Research, Inc. The company sells its products directly in the US, Canada and the UK and through distributors in Europe, South America and Asia. TearLab is headquartered in San Diego, California, the US.

TearLab Corp Key Recent Developments

May 10,2018: TearLab Announces First Quarter 2018 Financial Results
Mar 16,2018: TearLab Announces Voluntary Delisting From Toronto Stock Exchange
Mar 02,2018: TearLab Reports Fourth Quarter and Full Year 2017 Financial Results
Nov 13,2017: TearLab Reports Third Quarter and September Year-To-Date 2017 Financial Results
Aug 14,2017: TearLab Reports Second Quarter and First Half 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
TearLab Corp - Key Facts
TearLab Corp - Key Employees
TearLab Corp - Key Employee Biographies
TearLab Corp - Major Products and Services
TearLab Corp - History
TearLab Corp - Company Statement
TearLab Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
TearLab Corp - Business Description
TearLab Corp - SWOT Analysis
SWOT Analysis - Overview
TearLab Corp - Strengths
TearLab Corp - Weaknesses
TearLab Corp - Opportunities
TearLab Corp - Threats
TearLab Corp - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
TearLab Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018
TearLab Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018
TearLab Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 10, 2018: TearLab Announces First Quarter 2018 Financial Results
Mar 16, 2018: TearLab Announces Voluntary Delisting From Toronto Stock Exchange
Mar 02, 2018: TearLab Reports Fourth Quarter and Full Year 2017 Financial Results
Nov 13, 2017: TearLab Reports Third Quarter and September Year-To-Date 2017 Financial Results
Aug 14, 2017: TearLab Reports Second Quarter and First Half 2017 Financial Results
May 15, 2017: TearLab Corporation Reports First Quarter 2017 Financial Results
Mar 09, 2017: TearLab Corporation Reports Fourth Quarter and Year End 2016
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
TearLab Corp, Key Facts
TearLab Corp, Key Employees
TearLab Corp, Key Employee Biographies
TearLab Corp, Major Products and Services
TearLab Corp, History
TearLab Corp, Subsidiaries
TearLab Corp, Key Competitors
TearLab Corp, Ratios based on current share price
TearLab Corp, Annual Ratios
TearLab Corp, Annual Ratios (Cont...1)
TearLab Corp, Interim Ratios
TearLab Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018
TearLab Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018
TearLab Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
TearLab Corp, Performance Chart (2013 - 2017)
TearLab Corp, Ratio Charts
TearLab Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018
TearLab Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report